RU2726192C2 - Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения - Google Patents
Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения Download PDFInfo
- Publication number
- RU2726192C2 RU2726192C2 RU2017138283A RU2017138283A RU2726192C2 RU 2726192 C2 RU2726192 C2 RU 2726192C2 RU 2017138283 A RU2017138283 A RU 2017138283A RU 2017138283 A RU2017138283 A RU 2017138283A RU 2726192 C2 RU2726192 C2 RU 2726192C2
- Authority
- RU
- Russia
- Prior art keywords
- ester
- apocarotenoid
- hyaluronic acid
- bixin
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITFI2015A000102 | 2015-04-07 | ||
| ITFI20150102 | 2015-04-07 | ||
| PCT/IB2016/051960 WO2016162809A1 (en) | 2015-04-07 | 2016-04-07 | Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017138283A RU2017138283A (ru) | 2019-05-07 |
| RU2017138283A3 RU2017138283A3 (cg-RX-API-DMAC10.html) | 2019-09-30 |
| RU2726192C2 true RU2726192C2 (ru) | 2020-07-09 |
Family
ID=53719816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017138283A RU2726192C2 (ru) | 2015-04-07 | 2016-04-07 | Сложные эфиры гликозаминогликана, способы их получения и их применение в композициях офтальмического назначения |
Country Status (12)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000012535A1 (it) * | 2020-05-27 | 2021-11-27 | Stefano Colombo | Composizione oftalmica a base di acido ialuronico per la protezione dai danni causati dall’inquinamento ambientale |
| WO2022094695A1 (en) | 2020-11-03 | 2022-05-12 | Institut National De La Recherche Scientifique | A method and a system for compressed ultrafast tomographic imaging |
| CN116284495B (zh) * | 2023-03-20 | 2024-08-30 | 润辉生物技术(威海)有限公司 | 全反式维甲酸低分子透明质酸酯衍生物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2172169C2 (ru) * | 1995-03-28 | 2001-08-20 | Др. Герхард Манн Хем.-фарм.Фабрик ГмбХ | Стерильный капельножидкий офтальмологический гель-препарат и способ его производства |
| WO2004063364A1 (en) * | 2003-01-14 | 2004-07-29 | Sintofarm S.P.A. | Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells |
| US8865685B2 (en) * | 2011-06-30 | 2014-10-21 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1281877B1 (it) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici |
| ITTS20010017A1 (it) * | 2001-07-17 | 2003-01-17 | Ct Ricerche Polytech Soc Coop | Esteri polisaccaridici di acido retinoico. |
| ITMI20022745A1 (it) * | 2002-12-23 | 2004-06-24 | Coimex Scrl United Companies | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
| WO2005077176A1 (en) * | 2004-02-11 | 2005-08-25 | The Trustees Of Columbia University In The City Of New York | Anthocyanin compounds and methods of use thereof |
| ITMI20040347A1 (it) * | 2004-02-26 | 2004-05-26 | Pharma Medical Ltd | Nuovo farmaco di associazione |
| US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
| ITMI20062134A1 (it) * | 2006-11-08 | 2008-05-09 | Cbb Net S A | Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico |
| CA2886115A1 (en) * | 2012-10-02 | 2014-04-10 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
-
2016
- 2016-04-06 MA MA041912A patent/MA41912A/fr unknown
- 2016-04-07 WO PCT/IB2016/051960 patent/WO2016162809A1/en not_active Ceased
- 2016-04-07 JP JP2018503836A patent/JP6847091B2/ja not_active Expired - Fee Related
- 2016-04-07 RU RU2017138283A patent/RU2726192C2/ru active
- 2016-04-07 AU AU2016244391A patent/AU2016244391B2/en not_active Ceased
- 2016-04-07 BR BR112017021608A patent/BR112017021608A2/pt not_active IP Right Cessation
- 2016-04-07 CN CN201680025075.2A patent/CN107636020A/zh active Pending
- 2016-04-07 KR KR1020177032142A patent/KR20180002674A/ko not_active Ceased
- 2016-04-07 CA CA2981861A patent/CA2981861A1/en not_active Abandoned
- 2016-04-07 ES ES16726940T patent/ES2888648T3/es active Active
- 2016-04-07 EP EP16726940.6A patent/EP3280396B1/en active Active
- 2016-04-07 US US15/564,994 patent/US10328097B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2172169C2 (ru) * | 1995-03-28 | 2001-08-20 | Др. Герхард Манн Хем.-фарм.Фабрик ГмбХ | Стерильный капельножидкий офтальмологический гель-препарат и способ его производства |
| WO2004063364A1 (en) * | 2003-01-14 | 2004-07-29 | Sintofarm S.P.A. | Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells |
| US8865685B2 (en) * | 2011-06-30 | 2014-10-21 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
Non-Patent Citations (2)
| Title |
|---|
| Aicha Laabich et al., Investigative Ophthalmology & Visual Science, 2006, vol. 47, N 7, 3156-3157. * |
| Havener W.H. et al., Archeves of ophthalmology, American Medical association, 1959, vol. 61, N3, 390-401. * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3280396A1 (en) | 2018-02-14 |
| AU2016244391A1 (en) | 2017-11-23 |
| JP2018510962A (ja) | 2018-04-19 |
| CA2981861A1 (en) | 2016-10-13 |
| ES2888648T3 (es) | 2022-01-05 |
| AU2016244391B2 (en) | 2020-11-19 |
| US10328097B2 (en) | 2019-06-25 |
| CN107636020A (zh) | 2018-01-26 |
| RU2017138283A (ru) | 2019-05-07 |
| MA41912A (fr) | 2018-02-13 |
| WO2016162809A1 (en) | 2016-10-13 |
| JP6847091B2 (ja) | 2021-03-24 |
| BR112017021608A2 (pt) | 2018-07-03 |
| RU2017138283A3 (cg-RX-API-DMAC10.html) | 2019-09-30 |
| EP3280396B1 (en) | 2021-06-23 |
| US20180117077A1 (en) | 2018-05-03 |
| KR20180002674A (ko) | 2018-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1270599B1 (en) | Salmon-origin chondroitin sulfate | |
| CN101514177B (zh) | 从万寿菊颗粒中提取叶黄素的方法 | |
| EP3280396B1 (en) | Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use | |
| CN108779184A (zh) | 用于生物聚合物的脱乙酰化的方法 | |
| CN102648214B (zh) | 纯化透明质酸类的制造方法 | |
| Spin Neto et al. | Biomateriais à base de quitosana com aplicação médica e odontológica: revisão de literatura | |
| KR20150015209A (ko) | 저분자 아세틸화 히알루론산의 제조방법 및 이의 용도 | |
| JP2016518464A (ja) | ヒアルロン酸誘導体 | |
| Tamer et al. | Free radical scavenger activity of cinnamyl chitosan schiff base | |
| CN108003252A (zh) | 一种具有提高抗氧化活性的浒苔多糖羧甲基化修饰产物及其制备方法 | |
| WO2023131355A1 (zh) | 一种水溶性氯己定类抗菌剂及其制备方法和应用 | |
| CN108484795B (zh) | 硫酸软骨素锂及其制备方法和应用 | |
| JP4388368B2 (ja) | レチノイン酸の多糖エステル | |
| JP2015507070A (ja) | 部分的に解重合したグリコサミノグリカン銀及び金塩 | |
| CN111202746B (zh) | 一种眼用复合制剂及其制备方法 | |
| KR20200057144A (ko) | 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법 | |
| EA023370B1 (ru) | Хондроитинсульфат акульего типа и способ его получения | |
| WO2023125957A1 (zh) | 一种还原性透明质酸酯及其制备方法 | |
| JP2015117198A (ja) | コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法 | |
| JP6688498B2 (ja) | プロテオグリカンの分解方法及び分解物 | |
| CN116440061B (zh) | 一种药物矿化微棒、其制备方法及应用 | |
| EP3496761B1 (en) | Functionalized hyaluronic acid | |
| RU2473351C2 (ru) | Конъюгат гиалуроновой кислоты с новокаином с амфотерными свойствами | |
| CN117586432A (zh) | 一种透明质酸锌的制备方法及其应用 | |
| CN117530921A (zh) | 透明质酸-瑞巴派特偶联物及其制备方法和眼用滴眼液 |